Phillip P. Chan bought $105k of CTSO
Chief Executive Officer at Cytosorbents Corp. 261,469 shares at an average of $0.40, traded Jun 12, 2026, filed Jun 15, 2026.
Score components
- +25RoleCEO
- +10Trade size$105k at market
- +3Relative to holdingsHoldings up 18%
- +18Price context3% above the 52-week low; 69% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-074164, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | POpen-market purchase Common Stock | +251,136 | $0.40 | $100k | 1,734,099 | Jun 15, 2026 |
| Jun 15, 2026 | POpen-market purchase Common Stock | +10,333 | $0.43 | $4,443 | 1,744,432 | Jun 15, 2026 |
Related signals
Other insiders at Cytosorbents Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Cytosorbents Corp | Vincent Capponi President and COO | $13k 2,073 shares | +5% | |
| 45Moderate | Cytosorbents Corp | Phillip P. Chan Chief Executive Officer | $23k 3,774 shares | +4% | |
| 36Weak | Cytosorbents Corp | Alan D. Sobel director | $15k 2,500 shares | +34% | |
| 51Moderate | Cytosorbents Corp | Phillip P. Chan Chief Executive Officer | $70k 200,000 shares | +11% | |
| 47Moderate | Cytosorbents Corp | Peter J Mariani Chief Financial Officer | $44k 100,000 shares | +19% | |
| 30Weak | CTSObuy Cytosorbents Corp | Peter J Mariani Chief Financial Officer | $19k 20,000 shares | +5% | |
| 30Weak | CTSObuy Cytosorbents Corp | Peter J Mariani Chief Financial Officer | $28k 31,363 shares | +9% | |
| 51Moderate | Cytosorbents Corp | Michael G. Bator director | $50k 37,594 shares | +43% | |
| 55Moderate | Cytosorbents Corp | Kathleen P. Bloch Chief Financial Officer | $50k 37,594 shares | +9% | |
| 48Moderate | Cytosorbents Corp | Vincent Capponi President & COO | $25k 18,797 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.